ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,534,000 | +103.6% | 38,010 | +30.3% | 0.00% | – |
| Q3 2021 | $1,736,000 | +20.2% | 29,174 | +37.8% | 0.00% | – |
| Q2 2021 | $1,444,000 | -21.5% | 21,169 | -20.1% | 0.00% | -100.0% |
| Q1 2021 | $1,839,000 | -2.1% | 26,502 | +8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,878,000 | -14.9% | 24,451 | -17.1% | 0.00% | 0.0% |
| Q3 2020 | $2,208,000 | +240.7% | 29,507 | +186.4% | 0.00% | – |
| Q2 2020 | $648,000 | +66.6% | 10,304 | +11.3% | 0.00% | – |
| Q1 2020 | $389,000 | +80.1% | 9,257 | +94.8% | 0.00% | – |
| Q4 2019 | $216,000 | +83.1% | 4,753 | +84.0% | 0.00% | – |
| Q3 2019 | $118,000 | +24.2% | 2,583 | +59.4% | 0.00% | – |
| Q2 2019 | $95,000 | +46.2% | 1,620 | +12.0% | 0.00% | – |
| Q1 2019 | $65,000 | -8.5% | 1,447 | -21.0% | 0.00% | – |
| Q4 2018 | $71,000 | -53.6% | 1,832 | -45.1% | 0.00% | – |
| Q3 2018 | $153,000 | -78.6% | 3,337 | -79.6% | 0.00% | – |
| Q2 2018 | $714,000 | +462.2% | 16,383 | +409.3% | 0.00% | – |
| Q1 2018 | $127,000 | +4.1% | 3,217 | -10.9% | 0.00% | – |
| Q4 2017 | $122,000 | +5.2% | 3,610 | -20.6% | 0.00% | – |
| Q3 2017 | $116,000 | +2800.0% | 4,545 | +1965.9% | 0.00% | – |
| Q2 2017 | $4,000 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |